BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Arsenal Capital Partners Announces Sale Of Scientific Protein Laboratories, Inc.


8/18/2006 1:25:17 PM

NEW YORK, Aug. 18 /PRNewswire/ -- Arsenal Capital Partners , an industry- focused investor in lower-middle market, niche manufacturing and service companies, today announced the sale of its portfolio company Scientific Protein Laboratories LLC and affiliated entities (together "SPL") to American Capital Strategies Ltd. . SPL is a leading global independent manufacturer and supplier of biologic active pharmaceutical ingredients (APIs), including heparin and pancreatin APIs. Arsenal initially acquired SPL in February 2004 from Wyeth. Terms of the transaction were not disclosed.

"With investments in niche healthcare companies like SPL, Priority Solutions, and Leis Medical, Arsenal is taking advantage of strong growth trends in the outsourced pharmaceutical and medical technology markets. We are actively pursuing new investments in these sectors," said James Marden, a Managing Director of Arsenal Capital Partners.

"We appreciate the efforts of Arsenal Capital Partners in helping SPL transition to a standalone company and position the company for its next stage of growth," said Scientific Protein Laboratories CEO David Strunce.

Banc of America Securities LLC acted as financial advisor to SPL in the transaction.

About Arsenal Capital Partners

Arsenal Capital Partners invests in specialty product and services companies in industries where it has substantial prior experience and expertise and can support management teams to drive growth and improve productivity. Arsenal focuses on growing, niche markets including healthcare, specialty chemicals, aerospace/defense, specialty components and distribution/logistics. For additional information please visit www.arsenalcapital.com.

Arsenal Capital Partners

CONTACT: Christopher Tofalli, +1-914-834-4334



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES